Avadel Pharmaceuticals PLC (AVDL) earnings · rev $169.1M
These earnings events as JSON? API free 100/dayAvadel Pharmaceuticals PLC (AVDL) is a drug manufacturers - specialty & generic company listed on US.
This AVDL earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.
Latest reported AVDL revenue for 2024-12-31 was $169.1M. Net income was -$48.8M. Revenue was up 504.8% from 2023-12-31 to 2024-12-31. AVDL currently screens at market cap $968.5M.
When the next AVDL 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.
The change that matters: Revenue was up 504.8% from 2023-12-31 to 2024-12-31. An earnings headline that ignores that move is noise.
Not investment advice. Full AVDL research stays on the stock page; the tape stays on the quote page.
AVDL earnings FAQ
What are AVDL's latest revenue and net income?
Latest cached Avadel Pharmaceuticals PLC (AVDL) revenue for Dec 31, 2024 was $169.1M. Net income was -$48.8M. Statements: https://lician.com/financials/avdl
What is AVDL's latest diluted EPS?
Latest cached Avadel Pharmaceuticals PLC (AVDL) diluted EPS for Dec 31, 2024 was -$0.51.
What period does the latest AVDL earnings print cover?
The latest cached Avadel Pharmaceuticals PLC (AVDL) earnings print covers Dec 31, 2024. The prior cached period on this page is Dec 31, 2023.
How did AVDL revenue change from the prior cached period?
Cached Avadel Pharmaceuticals PLC (AVDL) revenue was up 504.8% from $28.0M (Dec 31, 2023) to $169.1M (Dec 31, 2024). Statements: https://lician.com/financials/avdl
Where are AVDL earnings listed?
Cached earnings facts for Avadel Pharmaceuticals PLC (AVDL) are listed at https://lician.com/earnings/avdl. Statements: https://lician.com/financials/avdl
Not investment advice.